PROVECTUS PHARMA NORDIC AS
1466 STRØMMEN
Return on Equity
78,9Â %
Current Ratio
1,29
Debt-to-Equity Ratio
0
| Key figures (NOK) | 2022 | |
|---|---|---|
| Revenue | 36Â 075Â 000 | |
| Net Income | 1Â 316Â 000 | |
| Total Assets | 7Â 000Â 000 | |
| Total Equity | 1Â 668Â 000 |
| Income (NOK) | 2022 | |
|---|---|---|
| Revenue | 36Â 075Â 000 | |
| Expenditure | 33Â 086Â 000 | |
| Operating Profit | 2Â 990Â 000 | |
| Financial Income | 17Â 000 | |
| Financial Costs | 1Â 316Â 000 | |
| Financial Balance | −1 299 000 | |
| Earnings Before Tax | 1Â 691Â 000 | |
| Tax | 375Â 000 | |
| Net Income | 1Â 316Â 000 |
| Balance (NOK) | 2022 | |
|---|---|---|
| Total Fixed Assets | 116Â 000 | |
| Total Current Assets | 6Â 884Â 000 | |
| Total Assets | 7Â 000Â 000 | |
| Total Retained Equity | 1Â 554Â 000 | |
| Total Equity | 1Â 668Â 000 | |
| Total Long-Term Debt | 0 | |
| Total Current Debt | 5Â 332Â 000 | |
| Total Equity and Debt | 7Â 000Â 000 |
| Cash flow (NOK) | 2022 | |
|---|---|---|
| Sales Income | 36Â 075Â 000 | |
| Other Income | 0 | |
| Revenue | 36Â 075Â 000 | |
| Cost of Goods Sold | 28Â 250Â 000 | |
| Salary Costs | 1Â 493Â 000 | |
| Depreciation | 29Â 000 | |
| Impairment | 0 | |
| Expenditure | 33Â 086Â 000 | |
| Operating Profit | 2Â 990Â 000 | |
| Financial Income | 17Â 000 | |
| Financial Costs | 1Â 316Â 000 | |
| Financial Balance | −1 299 000 | |
| Dividends | 0 | |
| Net Income | 1Â 316Â 000 |
| Balance details (NOK) | 2022 | |
|---|---|---|
| Goodwill | 0 | |
| Total Intangible Assets | 116Â 000 | |
| Real Eastate | 0 | |
| Machinery and Plant Facilities | 0 | |
| Fixtures | 0 | |
| Total Tangible Assets | 0 | |
| Total Fiancial Fixed Assets | 0 | |
| Total Fixed Assets | 116Â 000 | |
| Stock | 908Â 000 | |
| Total Investments | 0 | |
| Cash, Bank | 4Â 354Â 000 | |
| Total Current Assets | 6Â 884Â 000 | |
| Total Assets | 7Â 000Â 000 | |
| Total Equity | 1Â 668Â 000 | |
| Short-Term Group Debt | 0 | |
| Total Long-Term Debt | 0 | |
| Creditors | 723Â 000 | |
| Unpaid Taxes | 27Â 000 | |
| Dividends | 0 | |
| Other Current Debt | 4Â 198Â 000 | |
| Total Current Debt | 5Â 332Â 000 | |
| Total Equity and Debt | 7Â 000Â 000 |
| Financial indicators | 2022 | |
|---|---|---|
| Return on Equity | 78,9Â % | |
| Debt-to-Equity Ratio | 0 | |
| Operating Profit Margin | 8,29Â % | |
| Current Ratio | 1,29 | |
| Quick Ratio | 1,56 | |
| Equity Ratio | 0,24 | |
| Gross Profit Margin | 21,69Â % |
Rotate your device to see the full table